Pharming Group Nv (PHAR) Live Share Price, Invest From India

Pharming Group Nv Stock Performance

as on March 12, 2026 at 6:56 am IST

Day's Low
Day's High
$15.60
Day's Price Range
$16.09
$15.87
1.70%
Downside
1.39%
Upside
52 Week's Low
52 Week's High
$7.50
52-Week Price Range
$21.34
$15.87
52.73%
Downside
34.47%
Upside

Pharming Group Nv share price movements today

Previous Close: $16.67
Open: $15.99
Volume: 245.3K
Day's Low - High: $15.60 - $16.09
52 Week Low - High: $7.50 - $21.34

Pharming Group Nv Historical Returns

1 Month Return: + 3.79 %
3 Month Return: -11.68 %
1 Year Return: + 105.17 %
3 Year Return: + 34.58 %
5 Year Return: + 18.24 %

Pharming Group Nv Stock Fundamentals & Key Indicators

Check Pharming Group Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

0.0125

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.61%

PE Ratio (TTM)

PEG Ratio

EBITDA

47.9M

Revenue (TTM)

362.3M

Profit Margin

0.11%

Return On Equity TTM

0.03%

Pharming Group Nv vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pharming Group Nv with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pharming Group Nv	BUY	$1.2B	18.24%	NA	0.11%
Alnylam Pharmaceuticals, Inc.	BUY	$42.8B	125.34%	138.96	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$126.8B	129.73%	32.58	32.94%
Beone Medicines Ltd	NA	$35.3B	NA	123.64	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$81.6B	64.31%	18.62	31.41%

Stock Returns calculator for Pharming Group Nv Stock including INR - Dollar returns

The Pharming Group Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Pharming Group Nv investment value today

Current value as on today

₹2,10,585

Returns

₹1,10,585

(+110.58%)

Returns from Pharming Group Nv Stock

₹1,05,039 (+105.04%)

Dollar Returns*

₹5,546 (+5.55%)

Analyst Recommendation on Pharming Group Nv Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Pharming Group Nv. Average target price of $31

Pharming Group Nv Share Price Target

Get share price movements and forecasts by analysts on Pharming Group Nv.

What analysts predicted

48.81%UPSIDE

Target Price

$31

Current Price

$15.87

Analyzed by

14 Analysts

Target

$31.00

Pharming Group Nv target price $31, a slight upside of 48.81% compared to current price of $15.87. According to 14 analysts rating.

Pharming Group Nv Stock’s Investor Sentiment and Interest

Search interest for Pharming Group Nv Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: February 10, 2026 to March 12, 2026

Change:-10% versus previous 30 day period

Pharming Group Nv Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	54	66	81	55	74	74	92	79	93	97
Gross Profit	49	58	74	47	66	68	80	70	84	90
Operating Income	5	1	0	-16	-3	4	13	-7	10	15
EBITDA	6	4	8	-9	-4	7	-	-4	9	23
Interest Expense	2	1	4	1	1	2	1	5	0	7
Depreciation	3	2	7	5	0	2	7	2	2	2
Income Before Tax	3	3	-2	-16	0	1	6	-11	7	12
Income Tax Expense	2	0	0	-4	1	2	-	3	2	5
Net Income	1	3	-2	-12	-1	-1	2	-14	4	7
Net Profit Margin	2.40%	5.20%	-3.33%	-22.39%	-1.62%	-1.38%	3.09%	-18.61%	5.04%	7.76%

Pharming Group Nv Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	11	16	107	154	189	212	198	205	245	297
Gross Profit	6	11	92	129	165	188	177	188	220	261
Operating Income	-14	-12	26	43	68	76	13	18	-5	-8
EBITDA	-14	-13	-39	50	71	58	48	33	9	16
Interest Expense	0	3	21	16	13	10	6	5	5	8
Depreciation	-	-	3	6	5	7	16	13	15	16
Income Before Tax	-10	-18	-107	0	52	44	23	14	-12	-8
Income Tax Expense	0	3	-11	-27	11	6	7	1	-1	3
Net Income	-10	-18	-95	28	40	37	15	13	-10	-11
Net Profit Margin	-91.96%	-110.48%	-89.22%	18.50%	21.41%	17.79%	8.04%	6.65%	-4.30%	-3.98%

Pharming Group Nv Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	3	-2	-16	-1	-1	3	-11	7	7
Operating Cash Flow	3	12	-7	-13	9	9	0	11	30
Investing Cash Flow	-58	-	0	36	4	-	9	16	-2
Financing Cash Flow	5	-1	-2	-28	-1	-2	-6	-2	11
Change in Cash	-50	6	-9	-4	13	-2	5	31	38

Pharming Group Nv Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	26	43	52	44	23	14	-12	-8
Operating Cash Flow	-10	45	46	74	83	37	22	-17	-1
Investing Cash Flow	-60	-7	-4	-28	-15	-21	5	-129	31
Financing Cash Flow	70	-3	-20	-63	60	-27	-4	-1	-34
Change in Cash	0	33	24	-17	130	-13	15	-145	-6

Global Institutional Holdings in Pharming Group Nv

Funds	Holdings
SBI Securities Co Ltd	0%
Silverberg Bernstein Capital Management LLC	0.07%
Coldstream Capital Management Inc	0%
SBI Securities Co Ltd	0%
Morgan Stanley - Brokerage Accounts	0.01%

See all

Insights on Pharming Group Nv

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PHAR has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 79.09M → 97.28M (in $), with an average increase of 9.7% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -14.71M → 7.54M (in $), with an average increase of 225.7% per quarter
POSITIVE IMPACT
Price Rise
In the last 1 year, PHAR stock has moved up by 105.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 75.4% return, outperforming this stock by 40.8%

About Pharming Group Nv

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Organisation	Pharming Group Nv
Headquarters	Darwinweg 24, Leiden, Netherlands, 2333 CR
CEO	Mr. Fabrice Chouraqui Ph.D., Pharm.D.
E-voting on shares	Click here to vote

Key Management of Pharming Group Nv

Name	Title
Mr. Kenneth Lynard EMBA	Chief Financial Officer
Ms. Mireille Sanders M.Sc.	Chief Operations Officer
Ms. Susanne Embleton	Investor Relations Manager
Dr. Alexander Breidenbach M.B.A.	Chief Business Officer
Ms. Leverne Marsh	Chief Commercial Officer
Mr. Fabrice Chouraqui Ph.D., Pharm.D.	CEO & Executive Director
Mr. Michael K. Levitan	VP of Investor Relations & Corporate Communications
Ms. Ines Bernal	Chief People Officer
Dr. Anurag Relan M.D., MPH	Chief Medical Officer
Mr. Ruud Van Outersterp	Chief Legal & Compliance Officer

FAQs

What is Pharming Group Nv share price today?

Pharming Group Nv share price today is $15.87 as on March 12, 2026 at 1:26 am IST at the close of the market. Pharming Group Nv share today touched a day high of $16.09 and a low of $15.6.

What is the 52 week high and 52 week low for Pharming Group Nv share?

Pharming Group Nv share touched a 52 week high of $21.34 on January 27, 2026 and a 52 week low of $7.5 on April 3, 2025. Pharming Group Nv stock price today i.e. March 12, 2026 at 1:26 am IST is closed at $15.87,which is 25.63% down from its 52 week high and 111.55% up from its 52 week low.

What is Pharming Group Nv's market capitalisation today?

Pharming Group Nv market capitalisation is $0.00T as on March 12, 2026 at 1:26 am IST.

How to invest in Pharming Group Nv Stock (PHAR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pharming Group Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pharming Group Nv Shares that will get you 0.0945 shares as per Pharming Group Nv share price of $15.87 per share as on March 12, 2026 at 1:26 am IST.

What is the minimum amount required to buy Pharming Group Nv Stock (PHAR) from India?

Indian investors can start investing in Pharming Group Nv (PHAR) shares with as little as ₹92.04 or $1 (as of March 12, 2026 at 4:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹920.40 in Pharming Group Nv stock (as per the Rupee-Dollar exchange rate as on March 12, 2026 at 4:41 pm IST). Based on Pharming Group Nv share’s latest price of $15.87 as on March 12, 2026 at 1:26 am IST, you will get 0.6301 shares of Pharming Group Nv. Learn more about fractional shares .

What are the returns that Pharming Group Nv has given to Indian investors in the last 5 years?

Pharming Group Nv stock has given 18.24% share price returns and 26.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?